GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system.
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Total raised: $177M
Founded date: 2020
Investors 3
| Date | Name | Website |
| 13.08.2021 | T1D Fund | t1dfund.or... |
| - | RA Capital... | racap.com |
| - | OrbiMed | orbimed.co... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 11.08.2021 | Series A | $157M | - |
| 05.08.2020 | Seed | $20M | RA Capital... |
Mentions in press and media 11
| Date | Title | Description | Source |
| 16.08.2021 | GentiBio Raises $157M in Series A Financing | GentiBio, Inc., a Boston, MA-based biotherapeutics company developing engineered regulatory T cells ... | finsmes.co... |
| 11.08.2021 | GentiBio Announces $157M Series A Financing to Advance Engin... | - | orbimed.co... |
| 11.08.2021 | The rise of startups…for startups | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 11.08.2021 | GentiBio Announces $157M Series A Financing to Advance Engin... | BOSTON, Aug. 11, 2021 /PRNewswire/ -- GentiBio, Inc., a biotherapeutics company developing engineere... | marketscre... |
| 11.08.2021 | GentiBio Announces $157M Series A Financing to Advance Engin... | BOSTON, Aug. 11, 2021 /PRNewswire/ -- GentiBio, Inc., a biotherapeutics company developing enginee... | prnewswire... |
| 11.08.2021 | The rise of startups…for startups | Good morning, Term Sheet readers. Finance reporter Anne Sraders here again, filling in for Lucinda w... | fortune.co... |
| 05.08.2020 | GentiBio Raises $20M in Seed Funding | GentiBio, Inc., a Seattle, WA-based biotherapeutics company developing engineered regulatory T cells... | finsmes.co... |
| 05.08.2020 | GentiBio Launches with $20M Seed Funding | BOSTON, MA, GentiBio has closed a $20 million seed funding led by OrbiMed, Novartis Venture Fund a... | vcnewsdail... |
| 05.08.2020 | GentiBio Launches with $20M Seed Funding from OrbiMed, Novar... | - | orbimed.co... |
| 05.08.2020 | Novartis-backed biotech startup GentiBio launches with $20M ... | GentiBio, a Seattle-based biotherapeutics tech startup has closed a $20 million seed funding to deve... | techstartu... |
Show more